Delivery Order SPE2DB20D2001-SPE2DB24FM78R

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,827.51 firm-fixed-price Delivery Order covers the supply of Skyrizi 150 mg/ml prefilled pens, a specialty medication. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,827.51 firm-fixed-price delivery order is for the supply of the drug Skyrizi (360 mg/2.4 ml) to support federal healthcare programs. The award has a completion date of September 13, 2024 and is not set aside for any special business categories. Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and...
This federal contract award is a delivery order with a ceiling value of $11,468.99 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a firm fixed-price pricing type, is for the delivery of the specialty drug Skyrizi (180 mg/1.2 ml) and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,332.34 delivery order contract is for the supply of SKYRIZI 150 MG/ML PENML, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024 and is a firm fixed price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,121.07 firm fixed-price delivery order is for the supply of Skyrizi 150 mg/ml syringes. The contract has an ultimate completion date of January 6, 2025 and was awarded on January 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,141.00 firm fixed-price delivery order contract is for the supply of SKYRIZI 150 MG/ML PENML, a specialty medication. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,744.99 firm fixed-price delivery order is for the medication Skyrizi 150 mg/ml, with a completion date of November 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,827.51 firm fixed-price delivery order is for the supply of SKYRIZI 150 MG/ML PENML, a specialty medication. The contract has a completion date of November 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $102,950.53 firm fixed-price delivery order is for the drug Skyrizi (150 mg/mL), a medication used to treat certain medical conditions. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,604.63 firm fixed-price delivery order is for the supply of Skyrizi 360 mg/2.4 ml on-body 2.4 ml medication, with a completion date of April 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB24FM78R
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,827.51 firm fixed-price delivery order is for the medication Skyrizi, a specialty drug used for the treatment of certain medical conditions. The contract has an ultimate completion date of August 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award was not designated with any set-aside requirements.

Generated 2/27/25, 11:34 AM